Abstract
Thiabendazole is a new anthelmintic that is effective in the treatment of several helminthic diseases, including trichinosis, strongyloidiasis, and cutaneous larva migrans. In most patients the adverse reactions produced by thiabendazole are mild and subside when the drug is discontinued.

This publication has 0 references indexed in Scilit: